NTSIAVMC: Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China
Study Details
Study Description
Brief Summary
This register study will collect the treatment information of the intracranial arteriovenous malformation patients in China. We aim to understand the current treatment situation of the disease in China.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Intracranial arteriovenous malformations are congenital lesions that consist of multiple arteries and veins, connecting as a fistula without intervening normal capillary bed. The treatment strategy including surgical removal, endovascular embolism and stereotaxic radiosurgery and comprehensive treatment. China is a united multi-ethnic nation of 56 ethnic groups, and has the largest population in the world. We have most extensive and valuable clinical resources of intracranial arteriovenous malformation in the world. But we know little about the current treatment situation of the disease in China.
In order to realize the treatment situation of intracranial arteriovenous malformation in China, we designed a retrospective and prospective register study to collect the treatment and outcome information all over China.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Surgical treatment Surgical resection of intracranial arteriovenous malformations. |
|
Stereotaxic radiosurgery Deliver a relatively high dose of focused radiation precisely to the arteriovenous malformations. |
|
Endovascular treatment Deliver embolic materials to the feeding arteries or the nidus by microcatheters |
|
Comprehensive treatment Use two or three methods ( Surgical treatment stereotaxic radiosurgery endovascular treatment ) to cure the intracranial arteriovenous malformations |
|
Conservative treatment Patients refused to any of the treatment above |
Outcome Measures
Primary Outcome Measures
- modified Ranking Scale [six months after operation]
The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead
Secondary Outcome Measures
- Treatment complications [six months after treatment]
Post operative epilepsy seizure, hemorrhage,infarction;cerebral edemaćendovascular embolization injury
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All the patients that diagnosed of intracranial AVM by DSA/CT/MRI
-
All patients gave written informed consent
Exclusion Criteria:
- patients refuse to attend the survey
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University | Beijing | Beijing | China | 100050 |
Sponsors and Collaborators
- Dr. Yong Cao
Investigators
- Study Chair: Shuo Wang, MD, Beijing Tiantan Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IAVM-125R